Quick Takeaways:
- Cronos Group Inc. (CRON, Financial) saw a notable Q4 2024 financial performance with a reported GAAP EPS of $0.02.
- Q4 revenue reached $32.26 million, surpassing expectations by $0.37 million, largely attributed to contributions from GrowCo.
- The stock is forecasted to have a potential upside, with various price estimates and an "Outperform" brokerage recommendation.
Strong Q4 Financial Results for Cronos Group Inc.
Cronos Group Inc. (NASDAQ: CRON) has reported robust financial results for the fourth quarter of 2024, marking a positive trend for the cannabis firm. The company's GAAP EPS stood at $0.02, with total revenue hitting $32.26 million. This revenue performance exceeded expectations by $0.37 million, showing the significant impact of contributions from GrowCo and highlighting the company's growing financial strength.
Analyst Price Targets and Recommendations
Wall Street analysts have set one-year price targets for Cronos Group Inc., with an average target price of $2.43. The high estimate is pinned at $2.75, while the low estimate stands at $2.10. With the current stock price at $1.85, the average target suggests a potential upside of 31.08%. For more detailed estimates, visit the Cronos Group Inc (CRON, Financial) Forecast page.
The consensus from two brokerage firms places Cronos Group Inc. at an average brokerage recommendation of 2.5, indicating an "Outperform" status. This rating falls within a scale where 1 is a Strong Buy and 5 is Sell, showcasing a generally positive sentiment among analysts.
GF Value Estimate and Investment Potential
According to GF Value estimates, Cronos Group Inc. has a one-year projected value of $3.84. This suggests a significant upside of 107.57% from its current price of $1.85. The GF Value is GuruFocus's calculated estimate of what the stock should trade at, based on historical trading multiples, past business growth, and future performance projections. For further insights, explore the Cronos Group Inc (CRON, Financial) Summary page.
